Published in Gastroenterology on October 20, 2016
Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea. Clin Exp Gastroenterol (2017) 0.75
Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med (2011) 10.03
Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol (2011) 5.66
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature (2012) 5.63
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature (2013) 5.47
A G protein-coupled receptor responsive to bile acids. J Biol Chem (2003) 4.76
The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology (2007) 4.58
A population study of food intolerance. Lancet (1994) 4.54
ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol (2013) 4.36
Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology (2001) 4.30
Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger. Nat Genet (1998) 3.96
Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol (2008) 3.33
The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Am J Gastroenterol (2012) 3.11
Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology (2008) 3.04
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial. Gastroenterology (2015) 2.85
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut (2006) 2.82
Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu Rev Physiol (2000) 2.77
Tight junction pore and leak pathways: a dynamic duo. Annu Rev Physiol (2011) 2.67
TMEM16A inhibitors reveal TMEM16A as a minor component of calcium-activated chloride channel conductance in airway and intestinal epithelial cells. J Biol Chem (2010) 2.66
Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med (2008) 2.65
Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology (2007) 2.63
Development and validation of a scoring system to identify patients with microscopic colitis. Clin Gastroenterol Hepatol (2015) 2.63
Molecular physiology of intestinal Na+/H+ exchange. Annu Rev Physiol (2005) 2.58
The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology (1990) 2.32
The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol (2010) 2.30
Epithelial barriers in homeostasis and disease. Annu Rev Pathol (2010) 2.28
Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut (2008) 2.22
Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology (1988) 2.19
Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther (2015) 2.17
Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol (2012) 2.13
Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology (2012) 2.11
The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. Gut (1984) 2.11
Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study. Am J Gastroenterol (2014) 2.10
RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study. Am J Physiol Gastrointest Liver Physiol (2014) 2.10
Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest (2007) 2.09
Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion (2001) 2.05
Familial diarrhea syndrome caused by an activating GUCY2C mutation. N Engl J Med (2012) 2.04
Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol (2009) 2.02
The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroenterol (1979) 1.98
Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2008) 1.93
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol (2005) 1.93
Intestinal secretion: stimulation by peptides. Science (1971) 1.91
Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol (2007) 1.90
The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol (1996) 1.87
Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice. Gastroenterology (2013) 1.86
Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology (2006) 1.85
NHERF family and NHE3 regulation. J Physiol (2005) 1.81
Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol (2001) 1.79
cAMP and serum and glucocorticoid-inducible kinase (SGK) regulate the epithelial Na(+) channel through convergent phosphorylation of Nedd4-2. J Biol Chem (2004) 1.76
Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2012) 1.73
Passage of carbohydrate into the colon. Direct measurements in humans. Gastroenterology (1983) 1.73
The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc (2000) 1.72
Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology (2011) 1.70
Fecal osmotic gap and pH in experimental diarrhea of various causes. Gastroenterology (1992) 1.64
The emerging role of PDZ adapter proteins for regulation of intestinal ion transport. Am J Physiol Gastrointest Liver Physiol (2006) 1.64
Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system. Neurogastroenterol Motil (2010) 1.60
The diagnostic value of the duodenal biopsy: a clinico-pathologic analysis of 28,000 patients. Dig Liver Dis (2009) 1.58
Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol (2013) 1.57
Food-allergic reactions in schools and preschools. Arch Pediatr Adolesc Med (2001) 1.57
Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J Lab Clin Med (1979) 1.57
Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med (2009) 1.53
Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology (2010) 1.53
Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology (2009) 1.50
Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut (2012) 1.49
Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am J Physiol Regul Integr Comp Physiol (2003) 1.49
Clinical and Immunologic Features of Ultra-Short Celiac Disease. Gastroenterology (2016) 1.47
Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med (1993) 1.45
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol (2015) 1.44
A Breath of Fresh Air. Clin Gastroenterol Hepatol (2015) 1.41
Intakes and food sources of fructose in the United States. Am J Clin Nutr (1993) 1.39
The proximal colonic motor response to rectal mechanical and chemical stimulation. Am J Physiol Gastrointest Liver Physiol (2002) 1.38
Preliminary report: role of peptide YY in defence against diarrhoea. Lancet (1990) 1.37
Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol (2005) 1.37
Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol (2013) 1.34
The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology (2012) 1.33
Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol (2012) 1.32
Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology (2005) 1.30
Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am J Physiol Gastrointest Liver Physiol (2008) 1.28
Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther (2010) 1.24
Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol (2013) 1.23
Tight junction, selective permeability, and related diseases. Semin Cell Dev Biol (2014) 1.23
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis. Am J Gastroenterol (2015) 1.20
Epidemiology of food allergy/food intolerance in adults: associations with other manifestations of atopy. Allergy (2001) 1.20
Taurodeoxycholate modulates apical Cl-/OH- exchange activity in Caco2 cells. Dig Dis Sci (2007) 1.19
The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls. Gastroenterology (2011) 1.18
Regulation of the epithelial Na+ channel by peptidases. Curr Top Dev Biol (2007) 1.17
Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol (2003) 1.17
Severe weight loss caused by chewing gum. BMJ (2008) 1.16
Regulation of electroneutral NaCl absorption by the small intestine. Annu Rev Physiol (2011) 1.15
The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci (2012) 1.15
Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr (1996) 1.14
Ion transport in human colon in vitro. Gastroenterology (1987) 1.14
Intestinal fructose transport and malabsorption in humans. Am J Physiol Gastrointest Liver Physiol (2010) 1.13
Jejunal fluid and electrolyte secretion in carcinoid syndrome. Am J Dig Dis (1975) 1.11
Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology (1988) 1.09
Epithelial Na(+) channel regulation by cytoplasmic and extracellular factors. Exp Cell Res (2012) 1.08
Gastrointestinal Complications of Obesity. Gastroenterology (2017) 0.75
Martin F. Kagnoff, MD, January 19, 1941--November 16, 2014. Gastroenterology (2015) 0.75